{
    "code": "02003077",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02003077",
    "time": "2021-12-31 03:14:06",
    "許可證字號": "衛署藥輸字第003077號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/10\/28",
    "發證\/登錄日期": "63\/10\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "null",
    "中文品名": "利福全0.5毫克錠",
    "英文品名": "RIVOTRIL 0.5MG TABLET",
    "適應症": "癲癇",
    "劑型": "110錠劑",
    "包裝": "鋁箔盒裝(Alu-Alu)ALU-ALU鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "D第四級管制藥品",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CLONAZEPAM",
    "限制項目": "02輸　入 34第四級管制藥品",
    "申請商名稱": "620118D857  台灣大昌華嘉股份有限公司",
    "申請商地址": "臺北市內湖區堤頂大道2段407巷20弄1、3、5、7號10樓，及22、24、26號10樓及22號10樓之1",
    "主製造廠": [
        {
            "": "SPAIN",
            "製程": "包裝與製劑廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2824200300",
            "成分名稱": "CLONAZEPAM",
            "含量描述": "",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Rivotril 0.5mg_10146765_LAB bottle-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02003077&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Rivotril 0.5mg_CDS7.0_indication restriction_0519-RIV-01_(148x594)_排-108-05-20(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02003077&Seq=017&Type=9"
        },
        {
            "title": "Rivotril 0.5mg_CDS7.0_0419-RIV-01_(148x594)_排-108-04-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02003077&Seq=016&Type=9"
        },
        {
            "title": "20190322 Rivotril 0.5mg_003077-1-CTN-06-out-108-05-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02003077&Seq=007&Type=8"
        },
        {
            "title": "Rivotril 0.5mg_CTN_10146764-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02003077&Seq=006&Type=8"
        }
    ]
}